Sidekick Health and Lilly collaborate to support breast cancer patients
Digital therapeutics (DTx) startup Sidekick Health has announced an integrated solution in conjunction with pharma firm Eli Lilly and Company for patients with breast cancer.
Through Sidekick’s platform, patients will be given access to a tailored digital treatment plan to promote behaviour modification and overcome barriers...
When it comes to digitalising healthcare organisations there are two major pitfalls.
If digitalisation is pursued in an IT and technology driven way, it can lead to painful implementations which leave clinicians scratching their heads.
On the other hand, coming from a use case point of view can lead to endless pilot schemes that never get scaled up – something Tobias Silberzahn, partner at...
PatientSource solution eliminates manual data gathering at Ichilov Hospital
A new electronic patient record (EPR) solution at Ichilov Hospital in Israel has reduced the time it takes clinicians to access patient data from six minutes to six seconds per appointment.
Amazon Web Services (AWS) selected UK vendor PatientSource to build the cloud-based solution, which integrates with hospital IT...
Women’s health startup Inne raises $10M
Berlin-based healthtech startup Inne has raised an additional $10 million (€9.3M) in funding led by DSM Venturing.
Borski Fund and Calm Storm Ventures also participated in the round, along with angels Taavet Hinrikus (Wise), Dr Fiona Pathiraja and Rolf Schromgens (Trivago).
Inne will use the investment to continue to develop its mini lab and platform to...
The National Institute for Health and Care Excellence (NICE) has recommended the Sleepio app as an effective alternative to sleeping pills.
In its guidance, NICE states the app, created by digital therapeutics (DTx) firm Big Health, is a safe and effective treatment for people suffering from insomnia.
It adds that the app could save the NHS money and reduce prescriptions of medicines such as...
Digital therapeutics firm, Sidekick Health has joined forces with pharma giant Pfizer to launch an integrated digital therapeutics solution for Atopic Dermatitis (AD).
The solution will be rolled-out in the UK first, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year.
This marks the next phase of a growing collaboration between Sidekick and Pfizer to...
Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme
Biotechnology firm Oxford Drug Design Limited (ODD) has raised £2.2M in funding from existing investors ACF Investors, o2h Ventures, Meltwind Advisory, several returning angels and new investors and the US-based R42 Group.
The Oxford University spinout has created an artificial intelligence (AI) AI proprietary platform...
Demand for mental health services has soared since the COVID-19 pandemic. In the UK alone an estimated 1.6 million people are awaiting treatment, while a further eight million who do not qualify for NHS help are experiencing day-to-day challenges.
Increasingly digital therapeutics (DTx) are being considered as an option to fill the gaps in healthcare provision. They have the potential to be woven...
Free mental health app available to 1 million South Yorkshire NHS users
An emotional wellness app is being offered to over 16s in the UK's South Yorkshire for free, to help manage low moods, reduce stress and improve sleep.
The myStrength app has been commissioned by the South Yorkshire Integrated Care System (ICS) and is being delivered by Consultant Connect, part of the Teladoc Group.
Users are...
Digital therapeutics (DTx) firm Sidekick Health today announced a raise of $55 million (€52M) in Series B funding.
The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a US-based strategic investor that will be revealed at a later stage.
WHAT IT DOES
Sidekick develops and...
